|
|
|
|
|
by hef19898
1948 days ago
|
|
They ordered one slightly later than the UK and the US (let's ignore Israel which is basically a large scale trial). The main difference: the EU used normal certification processes, just sped them up considerably. The UK and US used emergncy certification. The volumes the EU ordered initially were absolutely sufficient with 4+ doses per EU inhabitant. Manufacturing capacities were sufficient for that as well. It all started to go south as soon as memeber states looked for scape goats why vaccination happened so slowly. First the manufacturers, then the EU, then the federal government (where applicable). It is a last-mile distribution issue if you will now, not a manufacturing one. |
|
Whether there is any truth in the EUs certification being conducted differently is a bit moot given they have approved the same vaccines based on the same trial data.